Tradjenta (linagliptin)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Tradjenta (linagliptin), covering 2016-05-17 to 2016-08-04. Get the full timeline:
Most recent: Clinical Trial Update: Bioequivalence of a FDC Tablet of Linagliptin/Metformin (5mg/1000mg) Extended Release in Healthy Subjects [Phase 1]